MedTrace Logo

Registration Trial of the Drug-coated Balloon for the Symptomatic Cerebral Atherosclerotic Stenosis

NCT06683118 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 212

Last updated 2024-11-12

No results posted yet for this study

Summary

The purpose of the trail is to determine whether DCB is superior to conventional balloon in treating cerebral atherosclerotic stenosis

Conditions

  • Cerebral Atherosclerotic Stenosis

Interventions

DEVICE

Rapamycin neurovascular Balloon Catheter

Drug-coated balloon for the symptomatic cerebral atherosclerotic stenosis

DEVICE

Conventional Balloon

Conventional Balloon for the symptomatic cerebral atherosclerotic stenosis

Sponsors & Collaborators

  • MicroPort NeuroTech Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-27
Primary Completion
2025-07-27
Completion
2026-07-27

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06683118 on ClinicalTrials.gov